News Posts List

A medical technology company out of Alpharetta has acquired Tampa-based Regenerative Medicine Solutions LLC, a biomedical services company in an all-stock transaction. 

Medovex Corp. was formed to acquire and develop a portfolio of medical tech products and services with disruptive characteristics, the statement said. RMS manages Lung Health Institute, which specializes in cellular therapies to treat chronic obstructive pulmonary disease and other chronic lung disorders.

Bill Horne, and founder and former CEO of Laser Spine Institute, is Medovex’s new CEO and chairman of the board of directors as of Oct. 9. Jarrett Gorlin resigned as president and CEO, a filing with the U.S. Securities and Exchange Commission said.

“I’m excited to join Medovex at what I view as an opportunistic time," Horne said in a statement. "I’ve long felt that the company’s DenerveX System represented a highly disruptive longer-term solution to chronic lower back pain associated with the Facet Joint, a sizeable market opportunity that continues to see large growth."

The purchase reunites Horne's former LSI executive management team, the statement said. Information about who else from the LSI team will be working with Horne is unavailable at this time as the deal is pending closing, a spokeswoman said. 

The company expects to target the acquisition of practices in the five cities where RMS has medical facilities: Tampa; Scottsdale, Arizona; Dallas; Pittsburgh; and Nashville, Tennessee. It will then pursue new markets. 

More than $32 billion was spent on COPD-related patient care in 2010, and those costs are projected to increase to $49 billion by 2020, the statement said.